Kelun Pharmacy (002422)
Sichuan Kelun Pharmaceutical (002422) Co., Ltd. is mainly engaged in the research, development, production and sales of 25 kinds of drugs, such as large-capacity injection (infusion), small-capacity injection (water injection), sterile powder injection for injection (including sub-packaged powder injection and freeze-dried powder injection), tablets, capsules, granules, oral liquid and peritoneal dialysis solution, as well as antibiotic intermediates, APIs and medical packaging materials. The main products cover anesthesia and analgesia, central nervous system, anti-infection, parenteral nutrition and other fields. In the past three years, 4 1 generic drugs have been approved for listing, 6/kloc-0 varieties have passed the consistency evaluation, 2 varieties of innovative drugs have been carried out clinical research in China and the United States, a new generation of tumor immune drug A293 has been approved for clinical use, and the first innovative drug A 167 has completed the critical phase II clinical efficacy evaluation. As a representative enterprise of domestic pharmaceutical innovation and high-quality development, the company won the honorary titles of "Top 20 R&D of China Pharmaceutical Group" and "Best Industrial Enterprise of R&D Product Line of China Pharmaceutical (600056)20 19". ...
Zhongmu shares (600 195)(600 195)
Zhongmu Industrial Co., Ltd. is mainly engaged in the research and development, production, sales and technical services of animal health products and animal nutrition products. The company's main business includes biological products, veterinary chemicals, feed and feed additives and trade. The main products are livestock vaccines, poultry vaccines, veterinary drugs, feed and feed additives. The company has the qualifications of National Enterprise Technology Center, Beijing Engineering Technology Research Center, Key Laboratory of Veterinary Biological Products and Chemicals of Ministry of Agriculture, postdoctoral workstation and CNAS. The company won the title of "National Integrity Unit of Product and Service Quality in 20 19" again, and its veterinary vaccines, feed and chemical products won the title of "National Quality Inspection Stable Qualified Products in 20 19".
*ST Hejia (300273)
Based on the research, development, manufacture and sales of medical equipment and consumables, Zhuhai Hejia Medical Equipment Co., Ltd. plans, designs and implements medical professional projects for public hospitals at all levels, and builds clinical key disciplines such as cancer centers, rehabilitation centers and intervention centers. The company mainly deals in four business segments: minimally invasive tumor treatment equipment, medical molecular sieve oxygen-making equipment and engineering, routine diagnosis and treatment equipment and medical equipment agent distribution. The company has been recognized as a national high-tech enterprise and a national independent intellectual property enterprise, and has set up a postdoctoral research mobile station in Hengqin New District of Zhuhai (the country) with the approval of the State Bo Guan Office.
New industry (300832)
The main business of Shenzhen New Industry Biomedical Engineering Co., Ltd. is the research and development, production, sales and service of in vitro diagnostic products, which is in a leading position in this field in China. The company's products are mainly used to provide diagnostic information for disease prevention, diagnosis, treatment monitoring, prognosis observation, health status evaluation and genetic disease prediction. New Industry Biology Company is the first company in China to adopt the most advanced "nano-immunomagnetic beads" as the key separation material of the system, the first company in China to use the most advanced "synthetic small molecular organic compounds" in this field to replace traditional enzymes as luminescent markers, and the first company in China to apply direct chemiluminescence immunoassay technology and realize the mass production of fully automatic chemiluminescence immunoassay instruments and supporting reagents.
Nuotai Biology (688076)
Jiangsu Nuotai Ossino Bio-pharmaceutical Co., Ltd. is a bio-pharmaceutical enterprise focusing on peptide drugs and small molecule drugs, which combines independent research and development with customized research and development. The company's main products are atorvastatin calcium tablets, amlodipine atorvastatin calcium tablets, APC 137 series, APC037, APC046, APC200, APC2 14, Aggliptide benzoate, etipatide, octreotide acetate, oseltamivir phosphate, GLP- 1/GIP/GCG receptor.
Fosun Pharma (600 196)
Shanghai Fosun Pharma (600 196) (Group) Co., Ltd. is mainly engaged in pharmacy, medical devices, medical diagnosis and medical health services. The main products are core products in the fields of cardiovascular disease treatment, central nervous system disease treatment, blood system disease treatment, metabolic and digestive system disease treatment, anti-infection disease treatment, anti-tumor treatment, raw materials and intermediates. According to the 20 18 list of the top 100 enterprises in China pharmaceutical industry published by People's Republic of China (PRC), China Pharmaceutical Industry Information Center of the Ministry of Industry and Information Technology, the Group ranked seventh; According to IQVIA's statistics, the sales revenue of hospital prescription drugs produced by the group in 20 19 was ranked 10 in the whole country. As one of the largest manufacturers of antimalarial drugs in the world, the group has become a drug procurement center for global funds, UNICEF, WHO and African countries. ...
Shengkangmei (6005 18)
Kangmei Pharmaceutical Co., Ltd. is mainly engaged in the production and sales of Chinese herbal pieces and chemicals, as well as the sales of outsourced products and the trade of Chinese herbal medicines. The company's main products include Chinese herbal pieces, Chinese herbal formula granules, Chinese patent medicines, western medicines, foods and health foods. The company is one of the enterprises with relatively complete business chain, rich medical and health resources and strong integration ability in the field of traditional Chinese medicine in China. The company mainly produces and operates Chinese herbal pieces, western medicine, health food and food, Chinese patent medicine, medical equipment and so on. At present, the company's traditional Chinese medicine decoction pieces business is in the leading position in the industry.
Tongrentang (600085)(600085)
The main business of Beijing Tongrentang Co., Ltd. is the research and development, production and sales of traditional Chinese medicine; The company's main products are Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Dahuoluo Pill. Tongrentang is a well-known Chinese time-honored brand in the field of Chinese medicine; Tongrentang's top ten ace products, Angong Niuhuang Pill, Tongren Niuhuang Qingxin Pill and Tongren Dahuoluo Pill, are well-known at home and abroad, and enjoy a good reputation in the treatment of clinical patients. The company covers 20 countries and regions and has 765,438+0 retail terminals, forming an international network layout of "based on China, based on Hongkong, deeply rooted in the mainstream and facing the world". The trademark "Tongrentang" used by the company belongs to Tongrentang Group, the controlling shareholder, and was recognized as a well-known trademark by the Trademark Office of the State Administration for Industry and Commerce in 1989.
TEDA (000652)
Tianjin TEDA Co., Ltd. (000652) is mainly engaged in domestic waste incineration power generation, sanitary landfill, kitchen, sludge treatment and biomass energy power generation and other related businesses. The company's main products and services are chemical and metal products trade, commercial housing, Guangling new city project, garbage disposal and power generation, textiles and filter materials. The company has won the second prize of National Science and Technology Progress Award, the first prize of Tianjin Science and Technology Progress Award twice, the National Patent Excellence Award and the Tianjin Patent Gold Award. It is the main compiling unit of many national standards and group standards, and ranks among the best in the national meltblown nonwovens industry.
Northeast Pharmaceutical (000597)(000597)
Northeast Pharmaceutical Group Co., Ltd. mainly covers chemical pharmacy (raw materials and preparations), pharmaceutical commerce (wholesale and chain), pharmaceutical engineering (pharmaceutical design, manufacturing and installation), biomedicine (biological diagnostic reagents) and other sectors, forming a pharmaceutical upstream and downstream industry and service cluster. The company has ten series of fine products such as vitamins, anti-infection products, reproductive system and sex hormone products, nervous system products, anti-AIDS products, digestive tract products, hemp essence and hemp-containing products, other generic products, in vitro (biological) diagnostic reagent products, and products in the field of big health, and more than 400 kinds of chemical raw materials, pharmaceutical intermediates and preparation products. The leading products are exported to more than 65,438+000 countries and regions.